A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi
Clinical trial NCT02625974 · COMPLETED
Trial details
- NCT number
- NCT02625974
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-27
- Primary completion
- 2018-07-25
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.